Home

timer Förkorta diskretion teva fda warning mikro Watt svamp

Teva halts output at U.S. drug plant after FDA flags concerns | Reuters
Teva halts output at U.S. drug plant after FDA flags concerns | Reuters

FDA Nod to New MS Drug Spells Trouble for Teva - Haaretz Com - Haaretz.com
FDA Nod to New MS Drug Spells Trouble for Teva - Haaretz Com - Haaretz.com

Teva's struggling sterile plant hit with FDA warning letter - Skyland  Analytics
Teva's struggling sterile plant hit with FDA warning letter - Skyland Analytics

Teva Pharmaceuticals Receive Warning Letter from FDA – Parker Waichman LLP
Teva Pharmaceuticals Receive Warning Letter from FDA – Parker Waichman LLP

Teva Shares Pop as FDA Approves Its Migraine Drug - TheStreet
Teva Shares Pop as FDA Approves Its Migraine Drug - TheStreet

FDA warns eye drops may cause infection. Here's a list of 27 products to  which the alert applies. - CBS News
FDA warns eye drops may cause infection. Here's a list of 27 products to which the alert applies. - CBS News

Teva Pharmaceuticals USA, Inc., Issues Voluntary Nationwide Recall of  Specific Lots of Fentanyl Buccal Tablets CII Because of Labeling Error |  ONS Voice
Teva Pharmaceuticals USA, Inc., Issues Voluntary Nationwide Recall of Specific Lots of Fentanyl Buccal Tablets CII Because of Labeling Error | ONS Voice

Generic Approvals Reshaping the SP Market | Anton Rx Report
Generic Approvals Reshaping the SP Market | Anton Rx Report

Teva Announces FDA Approval of AUSTEDO® XR (deutetrabenazine)  Extended-Release Tablets
Teva Announces FDA Approval of AUSTEDO® XR (deutetrabenazine) Extended-Release Tablets

Teva recalls one lot of leukemia med after finding particulates in vial |  Fierce Pharma
Teva recalls one lot of leukemia med after finding particulates in vial | Fierce Pharma

Teva Pharmaceutical | $TEVA Stock | Shares Rally After Winning FDA Approval  for Migraine Therapy - Warrior Trading News
Teva Pharmaceutical | $TEVA Stock | Shares Rally After Winning FDA Approval for Migraine Therapy - Warrior Trading News

Celltrion FDA warning causes headache for Teva's biologics ambition
Celltrion FDA warning causes headache for Teva's biologics ambition

FDA rejects Teva/Celltrion biosimilars | pharmaphorum
FDA rejects Teva/Celltrion biosimilars | pharmaphorum

Teva recalls one lot of IDArubicin Hydrochloride Injection USP
Teva recalls one lot of IDArubicin Hydrochloride Injection USP

Teva Issues Voluntary Nationwide Recall of One Lot of IDArubicin  Hydrochloride Injection USP 5 mg/5 mL Due to the Presence of Particulate  Matter | FDA
Teva Issues Voluntary Nationwide Recall of One Lot of IDArubicin Hydrochloride Injection USP 5 mg/5 mL Due to the Presence of Particulate Matter | FDA

FDA Issues Warning About Fake Adderall | Fox 8 Cleveland WJW
FDA Issues Warning About Fake Adderall | Fox 8 Cleveland WJW

Teva Receives FDA Warning Letter on China API Plant
Teva Receives FDA Warning Letter on China API Plant

Teva Recalls More Tainted Blood Pressure Drugs | BioSpace
Teva Recalls More Tainted Blood Pressure Drugs | BioSpace

FDA warning letter says Teva China plant has more work to do on API issues  | Fierce Pharma
FDA warning letter says Teva China plant has more work to do on API issues | Fierce Pharma

Teva Issues Voluntary Nationwide Recall of One Lot of Anagrelide Capsules |  DAIC
Teva Issues Voluntary Nationwide Recall of One Lot of Anagrelide Capsules | DAIC

FDA warns fake Adderall ADD medication being sold online
FDA warns fake Adderall ADD medication being sold online

ARS Pharma Shares Fall as FDA Declines to Approve Epinephrine Nasal Spray  Neffy - WSJ
ARS Pharma Shares Fall as FDA Declines to Approve Epinephrine Nasal Spray Neffy - WSJ

Teva's troubled Godollo plant earns firm US FDA warning letter
Teva's troubled Godollo plant earns firm US FDA warning letter

Teva confirms US FDA warning letter for Hangzhou, China API plant
Teva confirms US FDA warning letter for Hangzhou, China API plant

Teva China API plant smacked by FDA warning letter, adding to drugmaker's  burdens | Fierce Pharma
Teva China API plant smacked by FDA warning letter, adding to drugmaker's burdens | Fierce Pharma

Warfarin Sodium by Teva Pharmaceuticals USA, Inc. WARFARIN SODIUM tablet
Warfarin Sodium by Teva Pharmaceuticals USA, Inc. WARFARIN SODIUM tablet

FDA cites 'significant' sterility concern at Teva injectables plant |  Fierce Pharma
FDA cites 'significant' sterility concern at Teva injectables plant | Fierce Pharma

Teva Pharmaceuticals USA, Inc. Initiates Voluntary Nationwide Recall of  Metformin Hydrochloride Extended-Release Tablets USP 500 mg and 750 mg Due  to Detection of N-Nitrosodimethylamine (NDMA) | FDA
Teva Pharmaceuticals USA, Inc. Initiates Voluntary Nationwide Recall of Metformin Hydrochloride Extended-Release Tablets USP 500 mg and 750 mg Due to Detection of N-Nitrosodimethylamine (NDMA) | FDA